Therapeutics of postpartum depression

References

• Depression Fact Sheet. World Health Organization, 2016; [cited 2016 Jul 7]. Available from: http://www.who.int/mediacentre/factsheets/fs369/en/
   Google Scholar
• Pedersen CB, Mors O, Bertelsen A, et al. A comprehensive nationwide study of the incidence rate and lifetime risk for treated mental disorders. JAMA Psychiatry. 2014;71(5):573–581.
   PubMed Web of Science ®Google Scholar
• Wisner KL, Sit DKY, McShea MC, et al. Onset timing, thoughts of self-harm, and diagnoses in postpartum women with screen-positive depression findings. JAMA Psychiatry. 2013;70(5):490–498.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington (VA): American Psychiatric Publishing; 2013.
   Google Scholar
• Gaynes BN, Gavin N, Meltzer-Brody S, et al. Perinatal depression: prevalence, screening accuracy, and screening outcomes. Evid Rep Technol Assess. 2005 Feb;(119):1–8.
   Google Scholar
• Sadat Z, Abedzadeh-Kalahroudi M, Atrian MK, et al. The impact of postpartum depression on quality of life in women after child’s birth. Iran Red Crescent Med J. 2014;16(2):e14995–e15002.
   PubMed Web of Science ®Google Scholar
• Mirhosseini H, Moosavipoor SA, Nazari MA, et al. Cognitive behavioral development in children following maternal postpartum depression: a review article. Electron Physician. 2015;7(8):1673–1679.
   PubMedGoogle Scholar
• Hendrick V, Altshuler LL, Suri R. Hormonal changes in the postpartum and implications for postpartum depression. Psychosomatics. 1998;39(2):93–101.
   PubMed Web of Science ®Google Scholar
• Brummelte S, Galea LA. Postpartum depression: etiology, treatment and consequences for maternal care. Horm Behav. 2016;77:153–166.
   PubMed Web of Science ®Google Scholar
• Mori T, Tsuchiya KJ, Matsumoto K, et al. Psychosocial risk factors for postpartum depression and their relation to timing of onset: the Hamamatsu Birth Cohort (HBC) study. J Affect Disord. 2011;135(1–3):341–346.
   PubMed Web of Science ®Google Scholar
• Di Florio A, Meltzer-Brody S. Is postpartum depression a distinct disorder? Curr Psychiatry Rep. 2015;17(10):76.
   PubMed Web of Science ®Google Scholar
• Sharma V, Khan M, Corpse C, et al. Missed bipolarity and psychiatric comorbidity in women with postpartum depression. Bipolar Disord. 2008;10(6):742–747.
   PubMed Web of Science ®Google Scholar
• Reck C, Struben K, Backenstrass M, et al. Prevalence, onset and comorbidity of postpartum anxiety and depressive disorders. Acta Psychiatr Scand. 2008;118(6):459–468.
   PubMed Web of Science ®Google Scholar
• Rihmer Z, Gonda X. Antidepressant-resistant depression and antidepressant-associated suicidal behaviour: the role of underlying bipolarity. Depress Res Treat. 2011;2011:906462. doi:10.1155/2011/906462.
   PubMedGoogle Scholar
• Sharma V. A cautionary note on the use of antidepressants in postpartum depression. Bipolar Disord. 2006;8(4):411–414.
   PubMed Web of Science ®Google Scholar
• Mandelli L, Sourey D, Bartova L, et al. Bipolar II disorder as a risk factor for postpartum depression. J Affect Disord. 2016;204:54–58.
   PubMed Web of Science ®Google Scholar
• Wesseloo R, Kamperman AM, Munk-Olsen T, et al. Risk of postpartum relapse in bipolar disorder and postpartum psychosis: a systematic review and meta-analysis. Am J Psychiatry. 2016;173(2):117–127.
   PubMed Web of Science ®Google Scholar
• Cooper PJ, Murray L. Course and recurrence of postnatal depression. Evidence for the specificity of the diagnostic concept. Br J Psychiatry. 1995;166(2):191–195.
   PubMed Web of Science ®Google Scholar
• Fisher SD, Wisner KL, Clark CT, et al. Factors associated with onset timing, symptoms, and severity of depression identified in the postpartum period. J Affect Disord. 2016;203:111–120.
   PubMed Web of Science ®Google Scholar
• Hendrick V, Altshuler L, Strousse T, et al. Postpartum and nonpostpartum depression: differences in presentation and response to pharmacologic treatment. Depress Anxiety. 2000;11(2):66–72.
   PubMed Web of Science ®Google Scholar
• Freeman MP, Smith KW, Freeman SA, et al. The impact of reproductive events on the course of bipolar disorder in women. J Clin Psychiatry. 2002;63(4):284–287.
   PubMed Web of Science ®Google Scholar
• Benazzi F. Prevalence of bipolar II disorder in atypical depression. Eur Arch Psychiatry Clin Neurosci. 1999;249(2):62–65.
   PubMed Web of Science ®Google Scholar
• Azorin JM, Angst J, Gamma A, et al. Identifying features of bipolarity in patients with first-episode postpartum depression: findings from the international BRIDGE study. J Affect Disord. 2012;136:710–715.
   PubMed Web of Science ®Google Scholar
• Angst J, Azorin JM, Bowden CL, et al. Prevalence and characteristics of undiagnosed bipolar disorder in patients with a major depressive episode: the BRIDGE study. Arch Gen Psychiatry. 2011;68(8):791–798.
   PubMed Web of Science ®Google Scholar
• Sharma V, Corpse C. Is your depressed postpartum patient bipolar? Curr Psychiatry. 2011;10(6):81–82.
   Google Scholar
• Munk-Olsen T, Laursen TM, Meltzer-Brody S, et al. Psychiatric disorders with postpartum onset: possible early manifestations of bipolar affective disorders. Arch Gen Psychiatry. 2012;69(4):428–434.
   PubMed Web of Science ®Google Scholar
• Brockington IF, Marginson FR, Schofield E, et al. The clinical picture of the depressed form of puerperal psychosis. J Affec Disord. 1988;15(1):29–37.
   PubMed Web of Science ®Google Scholar
• Pinheiro E, Bogen DL, Hoxha D. Sertraline and breastfeeding: review and meta-analysis. Arch Womens Ment Health. 2015;18:139–146.
   PubMed Web of Science ®Google Scholar
• Leopacher AK, Liebers D, Pirooznia M, et al. Distinguishing bipolar from unipolar depression: the importance of clinical symptoms and illness features. Psychol Med. 2015;45:2437–2446.
   PubMed Web of Science ®Google Scholar
• Brockington I. Postpartum psychiatric disorders. Lancet. 2004;363(9405):303–310.
   PubMed Web of Science ®Google Scholar
• Chaudron LH, Pies RW. The relationship between postpartum psychosis and bipolar disorder: a review. J Clin Psychiatry. 2003;64(11):1284–1292.
   PubMed Web of Science ®Google Scholar
• Seo HJ, Wang HR, Jun TY, et al. Factors related to suicidal behavior in patients with bipolar disorder: the effect of mixed features on suicidality. Gen Hosp Psychiatry. 2016;39:91–96.
   PubMed Web of Science ®Google Scholar
• Sockol LE, Epperson CN, Barber JP. A meta-analysis of treatments for perinatal depression. Clin Psychol Rev. 2011;31(5):839–849.
   PubMed Web of Science ®Google Scholar
• Milgrom J, Gemmill AW, Ericksen J, et al. Treatment of postnatal depression with cognitive behavioural therapy, sertraline and combination therapy: a randomised controlled trial. Aust N Z J Psychiatry. 2015;49(3):236–245.
   PubMed Web of Science ®Google Scholar
• Simidjian S, Goodman S. Nonpharmacologic intervention and prevention strategies for depression during pregnancy and the postpartum. Clin Obstet Gynecol. 2009;52(3):498–515.
   PubMed Web of Science ®Google Scholar
• Kennedy SH, Lam RW, Parikh SV, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. Introduction. J Affect Disord. 2009;117(1):S1–2.
   PubMed Web of Science ®Google Scholar
• Stowe Z, Casarella J, Landry J, et al. Sertraline in the treatment of women with postpartum major depression. Depression. 1995;3(1–2):49–55.
   Google Scholar
• Misri S, Abizadeh J, Albert G, et al. Restoration of functionality in postpartum depressed mothers: an open-label study with escitalopram. J Clin Psychopharmacol. 2012;32(5):729–732.
   PubMed Web of Science ®Google Scholar
• Roy A, Cole K, Goldman Z, et al. Fluoxetine treatment of postpartum depression. Am J Psychiatry. 1993;150(8):1273.
   PubMed Web of Science ®Google Scholar
• Cohen LS, Viguera AC, Bouffard SM, et al. Venlafaxine in the treatment of postpartum depression. J Clin Psychiatry. 2001;62(8):592–596.
   PubMed Web of Science ®Google Scholar
• Nonacs RM, Soares CN, Viguera AC, et al. Bupropion SR for the treatment of postpartum depression: a pilot study. Int J Neuropsychopharmacol. 2005;8(3):445–449.
   PubMed Web of Science ®Google Scholar
• De Crescenzo F, Perelli F, Armando M, et al. Selective serotonin reuptake inhibitors (SSRIs) for post-partum depression (PPD): a systematic review of randomized clinical trials. J Affect Disord. 2014;152-154:39–44.
   PubMed Web of Science ®Google Scholar
• Sharma V, Sommerdyk C. Are antidepressants effective in the treatment of postpartum depression? A systematic review. Prim Care Companion CNS Disord. 2013;15:6.
   Google Scholar
• Hantsoo L, Ward-O’Brien D, Czarkowski KA, et al. A randomized, placebo-controlled, double-blind trial of sertraline for postpartum depression. Psychopharmacology. 2014;231(5):939–948.
   PubMed Web of Science ®Google Scholar
• Bloch M, Meiboom H, Lorberblatt M, et al. The effect of sertraline add-on to brief dynamic psychotherapy for the treatment of postpartum depression: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry. 2012;73(2):235–241.
   PubMed Web of Science ®Google Scholar
• Sharp DJ, Chew-Graham C, Tylee A, et al. A pragmatic randomized controlled trial to compare antidepressants with a community-based psychosocial intervention for the treatment of women with postnatal depression: the RESPOND trial. Health Technol Assess. 2010;14(43):1–153.
   Web of Science ®Google Scholar
• Yonkers KA, Lin H, Howell HB, et al. Pharmacologic treatment of postpartum women with new-onset major depressive disorder: a randomized controlled trial with paroxetine. J Clin Psychiatry. 2008;69(4):659–665.
   PubMed Web of Science ®Google Scholar
• Wisner KL, Hanusa BH, Perel JM, et al. Postpartum depression: a randomized trial of sertraline versus nortriptyline. J Clin Psychopharmacol. 2006;26(4):353–360.
   PubMed Web of Science ®Google Scholar
• Misri S, Reebye P, Corral M, et al. The use of paroxetine and cognitive-behavioral therapy in postpartum depression and anxiety: a randomized controlled trial. J Clin Psychiatry. 2004;65(9):1236–1241.
   PubMed Web of Science ®Google Scholar
• Appleby L, Warner R, Whitton A, et al. A controlled study of fluoxetine and cognitive-behavioral counseling in the treatment of postnatal depression. BMJ. 1997;314(7085):932–936.
   PubMed Web of Science ®Google Scholar
• Gentile S. The safety of newer antidepressants in pregnancy and breastfeeding. Drug Saf. 2005;28(2):137–152.
   PubMed Web of Science ®Google Scholar
• Sie SD, Wennink JM, van Driel JJ, et al. Maternal use of SSRIs, SNRIs and NaSSAs: practical recommendations during pregnancy and lactation. Arch Dis Child Fetal Neonatal Ed. 2012;97(6):F472–F476.
   PubMed Web of Science ®Google Scholar
• Sharma V, Sommerdyk C, Xie B. Aripiprazole augmentation of antidepressants for postpartum depression: a preliminary report. Arch Womens Ment Health. 2015;18(1):131–134.
   PubMed Web of Science ®Google Scholar
• Wisner KL, Perel JM, Peindl KS, et al. Prevention of postpartum depression: a pilot randomized clinical trial. Am J Psychiatry. 2004;161(7):1290–1292.
   PubMed Web of Science ®Google Scholar
• Yonkers KA, Gotman N, Smith MV, et al. Does antidepressant use attenuate the risk of a major depressive episode in pregnancy? Epidemiology. 2011;22(6):848–854.
   PubMed Web of Science ®Google Scholar
• Wisner KL, Perel JM, Peindl KS, et al. Prevention of recurrent postpartum depression: a randomized clinical trial. J Clin Psychiatry. 2001;62(2):82–86.
   PubMed Web of Science ®Google Scholar
• Wisner KL, Wheeler SB. Prevention of recurrent postpartum major depression. Hosp Community Psychiatry. 1994;45(12):1191–1196.
   PubMedGoogle Scholar
• Yonkers KA, Blackwell KA, Forray A. Antidepressant use in pregnant and postpartum women. Annu Rev Clin Psychol. 2014;10:369–392.
   PubMed Web of Science ®Google Scholar
• Ross LE, Grigoriadis S. Selected pregnancy and delivery outcomes after exposure to antidepressant medication. JAMA Psychiatry. 2014;71(6):716–717.
   PubMed Web of Science ®Google Scholar
• Nikfar S, Rahimi R, Hendoiee N, et al. Increasing the risk of spontaneous abortion and major malformations in newborns following use of serotonin reuptake inhibitors during pregnancy a systematic review and updated meta-analysis. DARU J Pharm Sci. 2012;20:78–85.
   Web of Science ®Google Scholar
• Grigoriadis S, VonderPorten EH, Mamisashvili L, et al. Antidepressant exposure during pregnancy and congential malformations is there an association? A systematic review and meta-analysis of the best evidence. J Clin Psychiatry. 2014;74(4):e293–308.
   Web of Science ®Google Scholar
• Suppes T, Silva R, Cucchiaro J, et al. Lurasidone for the treatment of major depressive disorder with mixed features: a randomized, double-blind, placebo-controlled study. Am J Psychiatry. 2016;173(4):400–407.
   PubMed Web of Science ®Google Scholar
• Sharma V, Khan M, Sommerdyk C. Quetiapine in the acute treatment of bipolar postpartum depression: a chart review. J Clin Psychopharmacol. 2015;35(6):733–735.
   PubMed Web of Science ®Google Scholar
• Yatham LN, Kennedy SH, Parikh SV, et al. Canadian network for mood and anxiety treatments (CANMAT) and international society for bipolar disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord. 2013;15(1):1–44.
   PubMed Web of Science ®Google Scholar
• Sharma V, Sommerdyk C, Xie B, et al. Pharmacotherapy of bipolar II disorder during and after pregnancy. Curr Drug Saf. 2013;8(4):246–252.
   PubMedGoogle Scholar
• Doyle K, Heron J, Berrisford G, et al. The management of bipolar disorder in the perinatal period and risk factors for postpartum relapse. Eur Psychiatry. 2012;27(8):563–569.
   PubMed Web of Science ®Google Scholar
• Jentink J, Loane MA, Dolk H, et al. Valproate monotherapy in pregnancy and major congenital malformations. N Engl J Med. 2010;362(23):2185–2193.
   PubMed Web of Science ®Google Scholar
• Rihtman T, Parush S, Ornoy A. Developmental outcomes at preschool age after fetal exposure to valproate and lamotrigine: cognitive, motor, sensory and behavioral function. Reprod Toxicol. 2013;41:115–125.
   PubMed Web of Science ®Google Scholar
• Ottomani H, Gouraud A, Jonville-Bera AP, et al. Pregnancy outcome after first trimester exposure to valproate used in bipolar disorders. Meeting Abstracts the 2nd International OTIS-ENTIS Conference at the Hospital for Sick Children; 2014 Sept 19–21; Toronto, Canada; 100(7):532–533.
   Google Scholar
• Koren G, Nava-Ocampo AA, Moretti ME, et al. Major malformations with valproic acid. Can Fam Physician. 2006;52(4):441–447.
   PubMed Web of Science ®Google Scholar
• Diav-Citrin O, Shechtman S, Bar-Oz B, et al. Pregnancy outcome after in utero exposure to valproate evidence of dose relationship in teratogenic effect. CNS Drugs. 2008;22(4):325–334.
   PubMed Web of Science ®Google Scholar
• Wisner KL, Hanusa BH, Peindl KS, et al. Prevention of postpartum episodes in women with bipolar disorder. Biol Psychiatry. 2004;56:592–596.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence. Antenatal and postnatal mental health. [cited 2016 Nov 7]. Available from: https://www.nice.org.uk/guidance/qs115/resources/antenatal-and-postnatal-mental-health-75545299789765
   Google Scholar
• Eberhard-Gran M, Eskild A, Opjordsmoen S. Use of psychotropic medications in treating mood disorders during lactation: practical recommendations. CNS Drugs. 2006;20(3):187–198.
   PubMed Web of Science ®Google Scholar
• Kendall-Tackett K, Hale TW. The use of antidepressants in pregnant and breastfeeding women: a review of recent studies. J Hum Lact. 2010;26(2):187–195.
   PubMed Web of Science ®Google Scholar
• Rosso G, Albert U, Di Salvo G, et al. Lithium prophylaxis during pregnancy and the postpartum period in women with lithium-responsive bipolar I disorder. Arch Womens Ment Health. 2016;19:429–432.
   PubMed Web of Science ®Google Scholar
• Bergink V, Kushner SA. Lithium in pregnancy. Am J Psychiatry. 2014;171(7):712–715.
   PubMed Web of Science ®Google Scholar
• McKnight RF. Lithium toxicity profile: a systematic review and meta-analysis. Lancet. 2012;379(9817):721–728.
   PubMed Web of Science ®Google Scholar
• Yacobi S, Ornoy A. Is lithium really a teratogen? What can we conclude from the prospective versus retrospective studies? A review. Isr J Psychiatry Relat Sci. 2008;45(2):95–106.
   PubMed Web of Science ®Google Scholar
• Sharma V, Smith A, Maxmanian D. Olanzapine in the prevention of postpartum psychosis and mood episodes in bipolar disorder. Bipolar Disord. 2006;8:400–404.
   PubMed Web of Science ®Google Scholar
• Gentile S. Lithium in pregnancy: the need to treat, the duty to ensure safety. Expert Opin Drug Saf. 2012;11(3):425–437.
   PubMed Web of Science ®Google Scholar
• Infant and young child feeding. World Health Organization. [cited 2016 Jun 20]. Available from: http://www.who.int/mediacentre/factsheets/fs342/en/
   Google Scholar
• Uguz F, Sharma V. Mood stabilizers during breastfeeding: a systematic review of the recent literature. Bipolar Disord. 2016;18(4):325–333.
   PubMed Web of Science ®Google Scholar
• Uguz F. Second-generation antipsychotics during the lactation period: a comparative systematic review on infant safety. J Clin Psychopharmacol. 2016;36(3):244–252.
   PubMed Web of Science ®Google Scholar
• Sachs HC. The transfer of drugs and therapeutics into human breast milk: an update on selected topics. Pediatrics. 2013;132(3):e796–809.
   PubMed Web of Science ®Google Scholar
• Orsolini L, Bellantuono C. Serotonin reuptake inhibitors and breastfeeding: a systematic review. Hum Psychopharmacol. 2015;30(1):4–20.
   PubMed Web of Science ®Google Scholar
• Weissman AM, Levy BT, Martz AJ, et al. Pooled analysis of antidepressant levels in lactating mothers, breast milk and nursing infants. Am J Psychiatry. 2004;161(6):1066–1078.
   PubMed Web of Science ®Google Scholar
• Menon SJ. Psychotropic medication during pregnancy and lactation. Arch Gynecol Obstet. 2008;277(1):1–13.
   PubMed Web of Science ®Google Scholar
• Davanzo R, Copertino M, De Cuno A, et al. Antidepressant drugs and breastfeeding: a review of the literature. Breastfeed Med. 2015;3(1):4–20.
   Google Scholar
• Chad L, Pupco A, Bozzo P, et al. Motherisk update: update on antidepressant use during breastfeeding. Can Fam Physician. 2013;59:633–634.
   PubMed Web of Science ®Google Scholar
• Rampono J, Teoh S, Hackett LP. Estimation of desvenlafaxine transfer into milk and infant exposure during its use in lactating women with postnatal depression. Arch Womens Mental Health. 2011;14:49–53.
   PubMed Web of Science ®Google Scholar
• Haas JS, Kaplan CP, Darenboim D, et al. Bupropion in breast milk: an exposure assessment for potential treatment to prevent post-partum tobacco use. Tob Control. 2004;13(1):52–56.
   PubMed Web of Science ®Google Scholar
• Spinelli MG. Postpartum psychosis: detection of risk and management. Am J Psychiatry. 2009;166(4):405–408.
   PubMed Web of Science ®Google Scholar
• Nordmo E, Aronsen L, Wasland K, et al. Severe apnea in an infant exposed to lamotrigine in breast milk Ann. Pharmacother. 2009;43:1893–1896.
   Web of Science ®Google Scholar
• Wakil L, Eppernson EN, Gonzalez J, et al. Neonatal outcomes with the use of lamotrigine for bipolar disorder in pregnancy and breastfeeding: a case series and review of the literature. Psychopharmacol Bull. 2009;42:91–98.
   PubMedGoogle Scholar
• Sharma V, Mazmanian D. Sleep loss and postpartum psychosis. Bipolar Disord. 2003;5:98–105.
   PubMed Web of Science ®Google Scholar
• Wisner KL, Perel JM, Peindl KS, et al. Timing of depression recurrence in the first year after birth. J Affect Disord. 2004;78(3):249–252.
   PubMed Web of Science ®Google Scholar